Lineage dependency and lineage-survival oncogenes in human cancer
- 1 August 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 6 (8) , 593-602
- https://doi.org/10.1038/nrc1947
Abstract
Although cell-lineage and differentiation models dominate tumour classification and treatment, the recognition that cancer is also a genomic disease has prompted a reconfiguration of cancer taxonomies according to molecular criteria. Recent evidence indicates that a synthesis of lineage-based and genetic paradigms might offer new insights into crucial and therapeutically pliable tumour dependencies. For example, MITF (microphthalmia-associated transcription factor), which is a master regulator of the melanocyte lineage, might become a melanoma oncogene when deregulated in certain genetic contexts. MITF and other lineage-survival genes therefore implicate lineage dependency (or lineage addiction) as a newly recognized mechanism that is affected by tumour genetic alterations.Keywords
This publication has 101 references indexed in Scilit:
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- The genetics of malignant melanoma: lessons from mouse and manNature Reviews Cancer, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- The language of covalent histone modificationsNature, 2000